No Data
No Data
Gyre Therapeutics to Present at Sidoti Virtual Investor Conference
Gyre Therapeutics Welcomes Dr. Epstein to Leadership Team
Express News | Gyre Therapeutics Announces Appointment of David M. Epstein, Ph.d., to Board of Directors
Gyre Therapeutics Seeks Compliance Amid Board Reshuffle
Gyre Therapeutics Shares Are Trading Higher After the Company Announced That China's NMPA Approved Avatrombopag Maleate Tablets for the Treatment of CLD-associated Thrombocytopenia.
Express News | Gyre Therapeutics Shares Are Trading Higher After the Company Announced That China's NMPA Approved Avatrombopag Maleate Tablets for the Treatment of CLD-associated Thrombocytopenia
No Data